K214049: Leaseir MHR Xcell (FDA 510(k) & Recall Dossier)
U.S. FDA 510(k) Premarket Notification K214049 (Leaseir MHR Xcell, cleared 2022-06-02 for Leaseir Technologies, Slu) reconciled with CDRH recall records on Predicate Ledger.
| Regulatory Field | Verified FDA Record |
|---|---|
| FDA 510(k) Number | K214049 |
| Cleared Device Trade / Generic Name | Leaseir MHR Xcell |
| FDA Applicant on Filing | Leaseir Technologies, Slu |
| FDA 3-Letter Product Classification | Product Code GEX |
| FDA Substantial Equivalence Decision Date | 2022-06-02 |
| De-Broadcasted Recall Linkage | Linked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026) |
Inspect consolidated manufacturer lineage at Leaseir Technologies, Slu, compare peer devices under FDA Product Code GEX, or browse all 20 FDA clinical specialties.
Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.